BEST4: A Platform Trial to determine whether Cytosponge-biomarker technology reduces mortality from oesophageal cancer

Project: Research

Project Details

AcronymBEST4
StatusActive
Effective start/end date1/10/202230/09/2036

Collaborative partners

Funding

  • CRUK Cancer Research UK: £3,432,926.50